The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
about
A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.Gene identification in Alzheimer's disease.Alzheimer disease therapeutics.The effect of hormone therapy on olfactory sensitivity is dependent on apolipoprotein E genotype.APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomyNeuroplasticity in Alzheimer's disease.Pharmacogenomics for the treatment of dementia.Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo.The application of functional genomics to Alzheimer's disease.Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Spatial pattern separation differences in older adult carriers and non-carriers for the apolipoprotein E epsilon 4 allele.Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele.Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patientsPharmacogenetics in drug discovery and development: a translational perspective.Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivoMetabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.Novel natural structure corrector of ApoE4 for checking Alzheimer's disease: benefits from high throughput screening and molecular dynamics simulations.Cardiac channelopathy causing sudden death as revealed by molecular autopsy.Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function.The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study.Cognitive impairment and the role of the ApoE epsilon4-allele after stroke--a 13 months follow-up study.
P2860
Q33148552-79EE122E-F9FF-4CA9-AC75-6CB157224DF9Q34355252-1A518CC6-97C9-4806-B962-B90DA23EE5ABQ34393812-FB6D967C-191F-48E6-9AC6-061AB7986EF8Q34585447-56681EBC-9550-44BC-ADA3-A429E4482A68Q34881496-F5B0D417-EFF9-4198-878B-4B53F90D815FQ34976296-2BA70AAA-D01C-41F4-BCEB-47A5007DDDA7Q35009345-E71BFD09-63F4-4821-BDF5-B73F030AEA55Q35130848-E4895DC4-93D6-4E9E-83DB-1B43CCCF113EQ35207554-C69808E2-11D2-4E1C-881A-2200E59ED8B3Q35852564-AA809978-48EE-4C12-9EAF-421DC90D3823Q35895780-7216137B-2D21-4E78-8ACA-EBD9F07886FEQ36253930-E7BEE05E-163B-40AD-AACC-E23A06519025Q36504889-B16507F7-68CB-4B83-9C40-4EE4ED30BC36Q36951446-E811D4ED-7546-4AA9-B552-BCC1E5F088F2Q37031522-57649625-AEA1-4324-9841-6E210FC5F36EQ37248285-67F62EE5-E9B9-42CF-B544-BF27004DAC37Q37275470-DF81CF34-ED32-498C-AA37-ED3C6A23B414Q37337930-3C0A7DDA-FF33-4316-8376-DCCD9B9F2EE8Q38123911-70A3A321-5BF3-42BD-96C6-0E12ECDF0E01Q42857729-9C3745C2-911F-4CAC-B24B-0C23CE866880Q44615304-416F32A3-ECFF-4844-A33D-7A2B98E94C8AQ46644344-91223C52-26FB-4029-9FBE-A7C26264D183Q48549948-D6E45DA5-5F6D-4E3A-8B73-7C1E664D9E5EQ51796360-DC3A30C5-C415-43EB-9403-B1C8B72612C1
P2860
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@ast
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@en
type
label
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@ast
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@en
prefLabel
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@ast
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@en
P2093
P1476
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.
@en
P2093
A M Saunders
D J Crowther
D M Wallace
M K Trowers
R A Shimkets
S Blakemore
T A Mansfield
W J Strittmatter
P356
10.1016/S0925-4439(00)00035-1
P407
P577
2000-07-01T00:00:00Z